FDA Commissioner Marty Makary said during an interview with Bloomberg Television that his agency may expedite reviews of marketing applications of pharmaceutical manufacturers that seek to “equalize” ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...